Protocol summary

Study aim
Determining the effect of concomitant use of sucrose and swaddling during blood sampling on pain intensity in infants
Design
Clinical trial, with control group, double-blind, randomized and random allocation based on a sequence generated by computer software and will be performed by random block method to size 4.
Settings and conduct
Setting: Neonatal ward of Amirkola Hospital in Babol Methods: In the intervention groups, the use of sucrose and swaddle will start 2 minutes before blood sampling and will be maintained during blood sampling. the use of sucrose and swaddle will continue up to 2 minutes after blood sampling. None of interventions will be used in the control group.
Participants/Inclusion and exclusion criteria
Term neonates with a gestational age of 37-42 weeks - Stability of vital signs before sampling - No congenital or genetic abnormalities - No use of drugs, antidepressants and anticonvulsants by the mother during pregnancy- No surgery and receiving anesthesia drugs 6- No intubation
Intervention groups
Infants are randomly assigned to each of the four groups of "sucrose", "swaddle", "sucrose swaddle" and also "control group".
Main outcome variables
Intensity of pain during venous blood sampling in premature infants

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20200913048704N2
Registration date: 2021-07-13, 1400/04/22
Registration timing: prospective

Last update: 2021-07-13, 1400/04/22
Update count: 0
Registration date
2021-07-13, 1400/04/22
Registrant information
Name
Ali Zabihi
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 11 3219 0597
Email address
a.zabihi@mubabol.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2021-08-03, 1400/05/12
Expected recruitment end date
2021-09-03, 1400/06/12
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
The effect of concurrent use of swaddle and sucrose taste on the Intensity of pain During Venous Blood sampling in Neonate: A clinical trial Study
Public title
The effect of concurrent use of swaddle and sucrose taste on the Intensity of pain During Venous Blood sampling in Neonate: A clinical trial Study
Purpose
Health service research
Inclusion/Exclusion criteria
Inclusion criteria:
Term infants with a gestational age of 42-37 weeks Stability of vital signs before sampling No congenital or genetic abnormalities Non-use of drugs, antidepressants and anticonvulsants by the mother during pregnancy No surgery and receiving anesthesia and anesthesia drugs Lack of intubation
Exclusion criteria:
Abnormalities in the head and skull such as cleft lip and palate and atrial fibrillation Infants who experience more than grade II intraventricular hemorrhage during the study.
Age
From 1 day old to 28 days old
Gender
Both
Phase
N/A
Groups that have been masked
  • Participant
  • Data analyser
Sample size
Target sample size: 60
More than 1 sample in each individual
Number of samples in each individual: 1
Infant
Randomization (investigator's opinion)
Randomized
Randomization description
After applying the Inclusion and exclusion criteria the method of assigning the subjects will be random allocation by permutation block method. Randomizing is at individual level. The size of the blocks is 4 and in each block, each intervention group will be repeated once. As a result, we will have 24 different blocks, each of which will be numbered from 1 to 24 as desired. Then, using the statistical program code rdunif (n=15, b=24, a=1) in R software version 3.6.1, 15 blocks of 4 will be generated, which will produce a total of 60 sequences (It should be noted that this code generates 15 random numbers from the numbers 1 to 24, which are the number of blocks). Using this randomly generated list, infants will be placed in the "sucrose", "swaddle", "sucrose swaddle", and "control" groups. To hide the random allocation list, a special code will be assigned to each of the intervention groups that only the executor of plan is aware of. These codes are written on a piece of paper and placed in a sealed envelope. A unique code for each patient will be written on this paper as well as its envelope. A foil is also placed inside each envelope so that the envelopes are not legible under light. Each envelope also contains a white paper and a carbon. All envelopes are randomly placed in a larger box and sealed in the box. The main researcher, after reviewing the inclusion criteria and obtaining informed consent, as well as registering the patient's details in a special form, will contact the partner who has a random assignment list (except for the main researcher who is not involved in the patient recruitment and sample entry process) and randomization of that research sample will be done. Also, before opening the envelope, this person should write the name and surname and age of the person on the place marked on the envelope so that the writing falls on the paper inside the envelope.
Blinding (investigator's opinion)
Double blinded
Blinding description
Intervention groups are infants on whom blood sampling is performed. Infants are unaware of the effects of sucrose and swaddle and are actually blind to the purpose of the study. The analyzer is not aware of the intervention groups and therefore has no bias in interpreting the data.
Placebo
Not used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics committee of Babol University of Medical Sciences
Street address
University of Medical Sciences , Ganjafrooz Street , Babol , Mazandaran ,Iran
City
Babol
Province
Mazandaran
Postal code
47176-47745
Approval date
2020-08-10, 1399/05/20
Ethics committee reference number
IR.MUBABOL.REC.1399.256

Health conditions studied

1

Description of health condition studied
Intensity of pain During Venous Blood sampling in Preterm Neonates
ICD-10 code
ICD-10 code description

Primary outcomes

1

Description
Intensity of pain during venous blood sampling in preterm infants
Timepoint
2 minutes before, during and 2 minutes after blood sampling
Method of measurement
Neonatal Infant Pain Scale

Secondary outcomes

1

Description
Infant heart rate changes 15 minutes before, during and 15 minutes after intravenous sampling
Timepoint
2 minutes before, during and 2 minutes after intravenous sampling
Method of measurement
Cardiorespiratory monitoring device

Intervention groups

1

Description
Intervention group: Sucrose group: Infants who receive 24%sucrose from 2 minutes before injection to 2 minutes after injection. In this group, the standard 24%sucrose, 0/2 ml / kg is used with a 1 ml syringe without a needle.
Category
Prevention

2

Description
Intervention group: Swaddle group: Infants who are swaddled from 2 minutes before injection to 2 minutes after injection. Infants without clothes and with only one diaper, swaddle on a triangular cloth.
Category
Prevention

3

Description
Intervention group: Swaddle sucrose group: Infants who become both receive sucrose and swaddle from 2 minutes before injection to 2 minutes after injection.
Category
Prevention

4

Description
Control group: Control group: Infants who do not receive any of the interventions.
Category
Prevention

Recruitment centers

1

Recruitment center
Name of recruitment center
Amirkola Hospital
Full name of responsible person
Ibrahim Hejazian
Street address
Babol - Shafizadeh Amir Kola Children's Hospital
City
Babol
Province
Mazandaran
Postal code
4731-741151
Phone
+98 11 3235 4951
Email
amirkola_hospital1342@yahoo.com

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Babol University of Medical Sciences
Full name of responsible person
Reza Ghadimi
Street address
University of Medical Sciences , Ganjafrooz Street , Babol , Mazandaran ,Iran
City
Babol
Province
Mazandaran
Postal code
47176-47745
Phone
+98 11 3219 0595
Email
rezaghadimi@yahoo.com
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Babol University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Babol University of Medical Sciences
Full name of responsible person
Ali Zabihi
Position
Assistant professor
Latest degree
Ph.D.
Other areas of specialty/work
Nursery
Street address
Babol University of Medical Sciences, Ganjafrooz Street
City
Babol
Province
Mazandaran
Postal code
47176-47745
Phone
+98 11 3219 0595
Email
zabihi_alii@yahoo.com
Web page address

Person responsible for scientific inquiries

Contact
Name of organization / entity
Babol University of Medical Sciences
Full name of responsible person
Ali Zabihi
Position
Assistant professor
Latest degree
Ph.D.
Other areas of specialty/work
Nursery
Street address
Babol University of Medical Sciences, Ganjafrooz Street
City
Babol
Province
Mazandaran
Postal code
47176-47745
Phone
+98 11 3219 0595
Email
zabihi_alii@yahoo.com

Person responsible for updating data

Contact
Name of organization / entity
Babol University of Medical Sciences
Full name of responsible person
Ali Zabihi
Position
Assistant Professor
Latest degree
Ph.D.
Other areas of specialty/work
Nursery
Street address
Babol University of Medical Sciences, Ganjafrooz Street
City
Babol
Province
Mazandaran
Postal code
47176-47745
Phone
+98 11 3219 0595
Email
zabihi_alii@yahoo.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Yes - There is a plan to make this available
Study Protocol
Yes - There is a plan to make this available
Statistical Analysis Plan
Yes - There is a plan to make this available
Informed Consent Form
Yes - There is a plan to make this available
Clinical Study Report
Yes - There is a plan to make this available
Analytic Code
Yes - There is a plan to make this available
Data Dictionary
Yes - There is a plan to make this available
Title and more details about the data/document
The data will be provided to the interested parties in an encoded form in Excel format, taking into account ethical considerations.
When the data will become available and for how long
After completing the study
To whom data/document is available
Everyone
Under which criteria data/document could be used
After the publication of the article, all analyzes on the data are allowed by all interested people
From where data/document is obtainable
Correspond Author
What processes are involved for a request to access data/document
By sending an email
Comments
Loading...